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suggesting that the two cysteine residues are not required for
apoptosis or VDAC1 oligomerization.
doi:10.1016/j.bbabio.2010.04.217
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Proteins involved in apoptosis are still amatter of debate. Therefore,
we decided to check the effect of the presence of VDAC (voltage
dependent anion selective channel) on viability of Saccharomyces
cerevisiae cells following their exposure to H2O2 that is known to
induce apoptosis both in S. cerevisiae and in mammalian cells.
Mitochondria of S. cerevisiae contain only one channel-forming VDAC
isoform (VDAC1), which simplifies studies on the channel. Using S.
cerevisiae mutant depleted of VDAC1 (termed here VDAC) and the
isogenic wild type, we have shown that VDAC is important for
protection of S. cerevisiae cells against H2O2 treatment, particularly in
exponential growth phase that is known to be more affected by H2O2.
The increased viability of H2O2 pretreated exponentially growing cells
containing VDAC was accompanied by clear changes of the cytosol
redox state and was potentiated by minocycline, an antibiotic of the
tetracycline family that displays cytoprotective potency. The protective
effect of minocycline also coincided with distinct changes of cytosol
redox state. Thus, we conclude that the ability to change the cytosol
redox state following exposure to H2O2 or/andminocycline appears to
be an intrinsic feature of exponentially growing cells (young cells)
containing VDAC.Moreover, the ability seems to be crucial for both cell
viability and protective effect of minocycline.
doi:10.1016/j.bbabio.2010.04.218
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Mitochondria are essential for cell survival, providing sources of
cellular energy, as well as lying at the heart of apoptotic regulation.
Mitochondria-mediated apoptosis results in the efflux of a number of
potential apoptotic regulators, such as cytochrome c, to the cytosol,
triggering the caspases cascade and cell destruction. The precise
mechanism regulating cytochrome c release remains unknown, and the
molecular architecture of the cytochrome c conducting channel has yet to
be determined. There is substantial evidence suggesting that the voltage-
dependent anion channel-1 (VDAC1) is a critical player in apoptosis by
regulating the release of apoptogenic proteins from mitochondria in
mammalian cells (e.g. cytochrome c). However, the VDAC1 pore diameter
is about 3 nm, too small for protein transport. Therefore,wepropose that a
mega pore is created between the VDAC1 monomers, allowing cyto-
chrome c release. Here, the relationship between VDAC oligomerization
and apoptosis induction was examined. We demonstrate that apoptosis
induction by various stimuli, acting through different mechanisms, all
involving mitochondria, is accompanied by an up to 20-fold increase in
VDAC oligomerization, as revealed by chemical cross-linking. In addition,
VDAC1 oligomeric statewas directlymonitored in living cells using BRET2
(Bioluminescence Resonance Energy Transfer) in cells expressing
rVDAC1-GFP2and rVDAC1-Luciferase. TheBRET2signal, indicatingVDAC1
oligomerization, shows a dramatic increase upon cell exposure to
apoptotic stimuli. Conversely, the apoptosis inhibitor, DIDS, inhibits
staurosporine-induced VDAC1 oligomerization and decreased the BRET2
signal and apoptosis.Wepropose thatVDAC1oligomerization is a key step
in mitochondrial-mediated apoptosis representing a general mechanism
common to numerous apoptogens acting via different initiating cascades.
Targeting the VDAC oligomeric status, and hence apoptosis, offers
therapeutic strategies for combating cancers and neurodegenerative
diseases.
doi:10.1016/j.bbabio.2010.04.219
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Functioningofmitochondria requiresmaintaining the fluxof ATP, ADP,
and othermetabolites across themitochondrial outermembranewhich is
mediated primarily by Voltage Dependent Anion Channel (VDAC).
Functions of VDAC have been previously examined in a suspension of
isolated mitochondria by using biochemical methods and in electro-
physiological experiments with artificial phospholipid membranes. Here,
we applied Fluorescence Correlation Spectroscopy (FCS) to study the
regulationof the functional stateofVDACbymonitoring thedistributionof
fluorescently labeled ATP (BODIPY-FL-ATP) in a suspension of mitochon-
dria isolated from rat liver. The addition of non-energizedmitochondria to
the solutionofBODIPY-FL-ATP resulted inaccumulationof thedye in these
organelles as manifested in the appearance of FCS signal bursts of high
intensity originating from single mitochondria associated with dye
molecules. Unlabelled ATP markedly suppressed the BODIPY-FL-ATP
accumulation in mitochondria at micromolar concentrations. NADH and
NAD+, ofwhich the latterwas less effective, aswell as Koenig's polyanion,
the known VDAC inhibitor, also inhibited the BODIPY-FL-ATP accumula-
tion. The addition of hexokinase II (HKII) isolated from rat heart also led to
a decrease in the BODIPY-FL-ATP accumulation, while a 15-residue
peptide corresponding to the N-terminal domain of hexokinase did not
produce this action. The effect of HKII was partially reversed by the
hexokinase reaction product glucose 6-phosphate. Based on these results,
we surmise that the FCS-detected accumulation of BODIPY-FL-ATP in
mitochondria reflects ATP influx across the mitochondrial outer mem-
brane through VDAC. By using the newly developed approach, the
hexokinase-induced inhibition of the ATP flow mediated by VDAC was
revealed in isolated mitochondria under physiological conditions.
doi:10.1016/j.bbabio.2010.04.220
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B-cell chronic lymphocytic leukemia (CLL) is the most common
leukemia in the Western world accounting for 30% of all leukemias.
CLL is characterized by CD5-positive monoclonal B cells in the blood,
bone marrow and peripheral lymphoid organs, representing the
gradual accumulation of B cells that failed to undergo apoptosis due
to overexpression of anti-apoptotic and pro-survival proteins such as
Bcl-2 and hexokinase (HK). We have shown previously that Bcl-2 and
HK interact with the mitochondrial protein, the voltage-dependent
anion channel (VDAC). Along with having an important function in
cellular energy metabolism regulation, VDAC1 has a key role in
mitochondria-mediated apoptosis by participating in the release of
cytochrome c thereby inducing apoptosis, and by interacting with
apoptosis-regulating proteins. We have developed a VDAC1-based
cell-penetrating peptide, LP4-Antp, which corresponds to a sequence
within VDAC1 that is involved in HK and Bcl-2 interaction with
VDAC1. We previously demonstrated that the LP4-Antp peptide
induces apoptosis efficiently and specifically in cancer cell lines. The
anti-cancerous effect of LP4-Antp was examined on peripheral blood
mononuclear cells (PBMCs) isolated from blood samples of CLL
patients and healthy donors. LP4-Antp peptide induced a dramatic
cell death in PBMCs derived from CLL patients but not from healthy
donors with 50% cell death occurring at 2.2 µM peptide concentration.
Moreover, a correlation between the expression of CD5/CD19 double
positive lymphocytes and the extent of LP4-Antp-induced cell death
was obtained. These results indicate LP4-Antp specificity towards
cancerous CLL cells. HK-I and Bcl-2 were found to be highly expressed
in PBMCs derived from CLL patients in comparison to those isolated
from healthy donors. In addition, for the first timewe demonstrate the
overexpression of VDAC1 in leukemia. The finding that LP4-Antp
induces specific cell death in CLL cancer cells provides new
opportunities for the development of novel, more effective therapies
for this incurable disease and probably for various other cancers.
doi:10.1016/j.bbabio.2010.04.221
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